Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 80-0613664 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Our primary mission includes funding research to find a cure or treatment for duchenne muscular dystrophy. We are committed to saving this generation of children. When we work smart, leverage each dollar and work in close partnership with scientists and research companies, there is the promise for an end to duchenne. We are proud that 2 projects we've supported in early stages are now in clincial trial, and one is under review for fda approval. In the meantime, while we fight for the future for these boys, we are committed to being there for them and helping families right now in the present moment.
Principal Officer
Marissa Penrod
Total Revenue
$1.0M
FY2024
Total Expenses
$1.4M
FY2024
Net Assets
$1.4M
Program Ratio
77.6%
expenses on programs
Employees
4
Volunteers
8
Board Members
6
Voting
5
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.